Insider Monkey77d agoneutral
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com96d agoneutral
Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger StoryInsider Monkey167d agoneutral
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology PortfolioSimply Wall St.183d agoneutral
Stronger HIV Pipeline And Acquisition Charges Might Change The Case For Investing In Gilead Sciences (GILD)